Soleus Capital Management, L.P. Neuro Pace Inc Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Neuro Pace Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 2,312,957 shares of NPCE stock, worth $22.7 Million. This represents 2.0% of its overall portfolio holdings.
Number of Shares
2,312,957
Previous 2,608,168
11.32%
Holding current value
$22.7 Million
Previous $32.1 Million
19.62%
% of portfolio
2.0%
Previous 2.65%
Shares
12 transactions
Others Institutions Holding NPCE
# of Institutions
108Shares Held
21.4MCall Options Held
3.14MPut Options Held
68.6K-
Orbimed Advisors LLC San Diego, CA2.61MShares$25.7 Million1.04% of portfolio
-
Morgan Stanley New York, NY2.59MShares$25.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN1.38MShares$13.6 Million2.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$13.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.15MShares$11.3 Million0.22% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $244M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...